Clinical Trials Logo

Polycystic Ovary Syndrome (PCOS) clinical trials

View clinical trials related to Polycystic Ovary Syndrome (PCOS).

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT04852510 Completed - Clinical trials for Polycystic Ovary Syndrome (PCOS)

Amelioration of Polycystic Ovary Syndrome Related Disorders by Supplementation of Thymoquinone and Metformin

Start date: February 1, 2019
Phase: Phase 2/Phase 3
Study type: Interventional

Objective: To investigate the potential benefit of adding Thymoquinone to Metformin in alleviating symptoms of polycystic ovarian syndrome. Methods: 207 overweight and obese PCOS Patients were divided into two groups. Patients in Group A, received Metformin 500 mg three times daily for 6 months. Patients in Group B, received a combination of Metformin 500 mg and Thymoquinone in the form of Black Cumin oil 500 mg capsules three times daily for 6 months. Follow up was done after 3 and 6 months from the beginning of the study for evaluation of menstrual cycle pattern, body mass index, Waist circumference, Hip circumference, and Waist / Hip ratio, Oral glucose tolerance test, Glycosylated Hemoglobin A1C, Superoxide dismutase activity and Malondialdehyde concentration.

NCT ID: NCT04264832 Completed - Clinical trials for Polycystic Ovary Syndrome (PCOS)

Body Fat Distribution and Its Associated Factors in Chinese Women With Polycystic Ovary Syndrome

Start date: March 1, 2016
Phase:
Study type: Observational

To investigate the body fat distribution in chinese women with polycystic ovary syndrome (PCOS) and the association of those distribution with metabolic parameters, microeconomics, hormone profiles and psychological state.

NCT ID: NCT03792282 Completed - Clinical trials for Overweight and Obesity

Time-Restricted Feeding(TRF) on Overweight/Obese Women With Polycystic Ovarian Syndrome (PCOS)

TRF-PCOS
Start date: January 7, 2019
Phase: N/A
Study type: Interventional

The aims of the present study is to examine whether Time-Restricted Feeding (TRF) is a safe and effective regimen to improve insulin resistance and decrease body weight in overweight/obese Polycystic ovary syndrome (PCOS) patients over 16 weeks compared to reduced energy restriction.

NCT ID: NCT03547453 Completed - Clinical trials for Overweight and Obesity

Ovarian Ultrasonography for the Clinical Evaluation of Polycystic Ovary Syndrome

Start date: June 4, 2018
Phase:
Study type: Observational

The investigators would like to determine how aspects of adiposity and age influence ultrasound features of the ovaries which are used to diagnose polycystic ovarian syndrome (PCOS). The study will also compare anti-Müllerian hormone (AMH) levels against ultrasound features of the ovary to predict PCOS.

NCT ID: NCT03414957 Completed - Metabolic Syndrome Clinical Trials

Malay Women With PCOS and Their Association With Metabolic Syndrome

MPMSS
Start date: November 2012
Phase:
Study type: Observational [Patient Registry]

The abnormalities that characterize the Metabolic Syndrome (MetS) confer an increased risk of cardiovascular and other diseases. Women with Polycystic Ovary Syndrome (PCOS), the commonest endocrine disease among women of childbearing age, have an increased risk of developing MetS. 2) The prevalence of MetS in PCOS patients varies among different ethnic groups. Malaysia is a unique country with a multiethnic population. The 3 largest ethnic groups are the Malays, Chinese and Indians. Previous studies in India and China have been able to determine the incidence of PCOS amongst those ethnic groups, but as yet, there is no published data on the prevalence of this disorder amongst women of Malay ethnicity. In this study, I intend to discover the prevalence of MetS amongst Malay women with established PCOS.

NCT ID: NCT03151005 Completed - Obesity Clinical Trials

The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS

Start date: July 1, 2017
Phase: Phase 4
Study type: Interventional

Polycystic ovary syndrome (PCOS) is a health problem that affects one in 10 women of childbearing age, which is usually characterized by hormonal imbalance and metabolism problems such as hyperandrogenism and obesity. Diane 35 pills are classified as oral contraceptives, which effectively reduces circulating androgens and are treatment for hyperandrogenism caused androgenic skin symptoms and irregular menstrual cycles. GLP-1 Receptor Agonist(e.g. exenatide, liraglutide) have the effects of lowering blood sugar and weight control by inhibiting of gastric emptying and reducing food intake. This study aims to evaluate the effect of metformin-GLP-1 Receptor agonist combination versus metformin-Diane-35 combination treatment on lipid metabolism and cardiovascular risks in overweight polycystic ovarian syndrome (PCOS) patients.

NCT ID: NCT02429128 Completed - Clinical trials for Polycystic Ovary Syndrome (PCOS)

14 Weeks Exercise Training on Lean Women With and Without PCOS

Start date: July 2014
Phase: N/A
Study type: Interventional

The aim of this project is to investigate the pathophysiology of PCOS in regards to the metabolic profile including defects in insulin sensitivity in skeletal muscle and adipose tissue, and to investigate the effects of exercise training on these parameters.

NCT ID: NCT01999686 Completed - Insulin Resistance Clinical Trials

PCOS Treatment Using DLBS3233, Metformin, and Combination of Both

POSITIF
Start date: October 2014
Phase: Phase 3
Study type: Interventional

This is a 3-arm, randomized, double-blind, double-dummy, and controlled clinical study over 6 months of treatment to evaluate the metabolic and clinical efficacy as well as the safety of DLBS3233 alone, metformin and combination of both, in improving metabolic and reproductive parameters.

NCT ID: NCT01983202 Completed - Clinical trials for Polycystic Ovary Syndrome, PCOS

Obstetric Outcomes in Women With PCOS

Start date: January 2003
Phase: N/A
Study type: Observational

The aim of the study is to investigate body composition in newborn children of women with PCOS and controls and to investigate adverse obstetric outcomes in pregnant women with PCOS.

NCT ID: NCT01927471 Completed - Clinical trials for Polycystic Ovary Syndrome (PCOS)

Nutritional and Metabolic Correlates of Ovarian Morphology in Women With Polycystic Ovary Syndrome

Start date: September 2011
Phase:
Study type: Observational

The investigators would like to determine how aspects of metabolism and age influence ovarian function. The purpose of the study is to understand how nutrition and metabolism relate to follicle development in women with regular cycles, irregular cycles, or polycystic ovary syndrome (PCOS). We also plan to identify lifestyle factors associated with PCOS and understand how diet and activity levels impact features of PCOS.